Cargando…
Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models
BACKGROUND: Chemotherapeutic drugs and newly developed therapeutic monoclonal antibodies are adequately delivered to most solid and systemic tumors. However, drug delivery into primary brain tumors and metastases is impeded by the blood-brain tumor barrier (BTB), significantly limiting drug use in b...
Autores principales: | Hu, Jinwei, Ljubimova, Julia Y., Inoue, Satoshi, Konda, Bindu, Patil, Rameshwar, Ding, Hui, Espinoza, Andres, Wawrowsky, Kolja A., Patil, Chirag, Ljubimov, Alexander V., Black, Keith L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856671/ https://www.ncbi.nlm.nih.gov/pubmed/20419092 http://dx.doi.org/10.1371/journal.pone.0010108 |
Ejemplares similares
-
Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid)
por: Patil, Rameshwar, et al.
Publicado: (2012) -
Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
por: Inoue, Satoshi, et al.
Publicado: (2012) -
Multifunctional Nanopolymers for Blood–Brain Barrier Delivery and Inhibition of Glioblastoma Growth through EGFR/EGFRvIII, c-Myc, and PD-1
por: Patil, Rameshwar, et al.
Publicado: (2021) -
Quantitative Analysis of PMLA Nanoconjugate Components after Backbone Cleavage
por: Ding, Hui, et al.
Publicado: (2015) -
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
por: Ljubimova, Julia Y., et al.
Publicado: (2014)